Eric Lefkofsky, founder and CEO of Tempus AI, explains the impact of acquiring Ambry, a genetic testing company, which ...
In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, Media & Telecom ...
Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.
The company’s quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, ...
Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock.
Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.
Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care,” said Eric Lefkofsky, Founder and CEO of ...
neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
The company’s quarterly earnings will be released the same day. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results